#VisualAbstract: Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

byWinnie LiuandMinjee Kim

October 31, 2023

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Patisiran prevents functional decline in patients with cardiac amyloidosis

Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis

Patisiran is effective in treatment of hereditary transthyretin amyloidosis.

Tags: Patisiran transthyretin amyloidosis

Poor sleep efficiency is associated with improvements in episodic memory in older adults following a moderate-intensity exercise intervention

RelatedReports

Image-guided percutaneous drainage of pericardial effusions is safe and effective

Cardiology

Patisiran prevents functional decline in patients with cardiac amyloidosis

December 8, 2023

Cardiology

Patisiran therapy reduces ventricular myocardial strain in hereditary transthyretin amyloidosis

March 23, 2019

Amyloidogenic genetic variant not associated with increased mortality in blacks

Cardiology

Patisiran is effective in treatment of hereditary transthyretin amyloidosis.

August 1, 2018

The Scan by 2 Minute Medicine®: Performance-Enhancing Problems, Pride Tape Bans, a Bedbug Outbreak, and Picking up on Parkinson’s

#VisualAbstract: Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

Reinnervation of cardiac infarcts decreases subsequent arrhythmia incidence [PreClinical]

Extracorporeal membrane oxygenation increases bleeding risk in patients with cardiogenic shock

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result